AIM ImmunoTech Inc (AIM)
0.2611
0.00 (0.00%)
USD |
NYAM |
Nov 01, 16:00
0.25
-0.01
(-4.25%)
After-Hours: 20:00
AIM ImmunoTech Gross Profit Margin (Quarterly): 84.00% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 84.00% |
| March 31, 2024 | 80.00% |
| December 31, 2023 | 81.54% |
| September 30, 2023 | 34.78% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -130.0% |
| March 31, 2022 | -133.3% |
| December 31, 2021 | -252.0% |
| September 30, 2021 | -375.8% |
| June 30, 2021 | -1.11K% |
| March 31, 2021 | -746.4% |
| December 31, 2020 | -371.4% |
| September 30, 2020 | -466.7% |
| June 30, 2020 | -400.0% |
| March 31, 2020 | -353.3% |
| December 31, 2019 | -334.0% |
| September 30, 2019 | -277.0% |
| June 30, 2019 | -641.4% |
| March 31, 2019 | |
| December 31, 2018 | -17.50% |
| September 30, 2018 | -447.4% |
| June 30, 2018 | -463.6% |
| Date | Value |
|---|---|
| March 31, 2018 | -271.4% |
| December 31, 2017 | -492.0% |
| September 30, 2017 | -343.3% |
| June 30, 2017 | -2.35% |
| March 31, 2017 | -221.4% |
| December 31, 2016 | -1.64K% |
| September 30, 2016 | -1.14K% |
| June 30, 2016 | -1.83K% |
| March 31, 2016 | -587.2% |
| December 31, 2015 | -1.26K% |
| September 30, 2015 | -1.43K% |
| June 30, 2015 | -978.7% |
| March 31, 2015 | -933.3% |
| December 31, 2014 | -720.0% |
| September 30, 2014 | -580.0% |
| June 30, 2014 | -716.7% |
| March 31, 2014 | -325.0% |
| December 31, 2013 | -333.3% |
| September 30, 2013 | -600.0% |
| June 30, 2013 | -1.66K% |
| March 31, 2013 | -354.8% |
| December 31, 2012 | -867.9% |
| September 30, 2012 | -2.43K% |
| June 30, 2012 | -324.5% |
| March 31, 2012 | -288.9% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-1.11K%
Minimum
Jun 2021
84.00%
Maximum
Jun 2024
-293.0%
Average
-334.0%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 29.82% |
| Electromed Inc | 76.19% |
| Xtant Medical Holdings Inc | 62.06% |
| Armata Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -189.8% |
| Return on Assets | -124.4% |
| Return on Invested Capital | -177.3% |
| Profit Margin (Quarterly) | -3.67K% |
| Operating Margin (Quarterly) | -7.39K% |
| Return on Net Operating Assets | -830.8% |